Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Pivotal trial data reported for levalbuterol

March 19, 1997

Peptides for Japanese cedar allergies reported by Sankyo and Hayashibara

March 18, 1997

Astra gains European approval of asthma treatment

March 17, 1997

Bronchodilating effect of furosemide not secondary to prostaglandin release

March 14, 1997

Montelukast associated wth bronchodilating effects in asthmatics

March 14, 1997

Fluticasone associated with more adrenal suppression than budesonide

March 13, 1997

SS Pharm./Torii developing new antiallergic agent

March 13, 1997

Novel LT biosynthesis inhibitor discovered by Abbott

March 11, 1997

Fluticasone + loratadine for seasonal allergic rhinitis

March 10, 1997

Spiros products progressing through pipeline

March 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...